Timefolio Capital (formerly known as NS Investment) is a Seoul-based venture capital firm affiliated with Dong-A ST (and later Timefolio Asset Management) that invests in novel therapeutic and biotech companies, primarily in the US and Korea. It was established in 2015 as the biotech venture capital arm of Dong-A ST.
54% of their portfolio is in Biotech & Life Sciences. They made 1 investment in the last 12 months. Average disclosed round size is $69.0M (across 21 rounds with reported amounts).
Portfolio
24
Fund Size
—
Top Stage
Series B
Last 12 Mo
1
Team
KL
KyungEun LEE
투자 팀장
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
28 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| MMeissa | Seed | $3.4M | Apr 2026 |
| MMeissa | Series C | $6.8M | Jan 2026 |
 DeepX | Series C | $80M | May 2024 |
 Avelos Therapeutics | Series B | $12.3M | Apr 2024 |
 Accent Therapeutics | Series C | $75M | Jan 2024 |
| Avelos Therapeutics | Series A | $8M | Jan 2024 |
 Mezoo | Unknown | — | Nov 2023 |
 GenEdit | Series A | $26M | Jan 2023 |
 Enhans | Series A | — | Jan 2023 |
 BoostImmune | Series A | — | Jun 2022 |
 Aspen Neuroscience | Series B | $147.5M | May 2022 |
 Aspen Neuroscience | Series B | — | May 2022 |
 Dewpoint Therapeutics | Series C | $150M | Feb 2022 |
| DDewpoint | Series C | $150M | Jan 2022 |
 Shoreline Biosciences | Series D | $140M | Nov 2021 |
 Immunitas Therapeutics | Series B | $58M | Aug 2021 |
| IImmunitas | Series B | $58M | Aug 2021 |
| RReCode | Series B | $50M | Jan 2021 |
 ReCode Therapeutics | Series B | $50M | Jan 2021 |
| Accent Therapeutics | Series B | $63M | Apr 2020 |
 Antiva Biosciences | Series C | $22M | Mar 2017 |
| Antiva Biosciences | Series C | $22M | Jan 2017 |
 Inventage Lab | Unknown | — | — |
 Stradvision | Series B | $27M | — |
 Medimabbio | Series B | — | — |
Page 1 of 2
Top Co-Investors
Mirae Asset11 shared
Leaps by Bayer8 shared
ARCH Venture Partners5 shared
Alexandria Venture Investments5 shared
AJU IB Investment5 shared
Maverick Ventures4 shared
3E Bioventures Capital4 shared
General Catalyst4 shared
Mubadala Ventures4 shared
Samsara BioCapital4 shared
Polaris Partners4 shared
GV4 shared
OrbiMed4 shared
Solasta Ventures4 shared
Osage University Partners4 shared
Alphabet Inc.3 shared
Smilegate Investment3 shared
SV Investment Corporation3 shared
Lifeforce Capital2 shared
EDBI2 shared
Last updated: 20 October 2026